Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Kymera Therapeutics advances Phase 2 trials of KT-474 in partnership with Sanofi Kymera Therapeutics, Inc. (NASDAQ: KYMR), a leader in the biopharmaceutical sector focusing on targeted protein degradation (TPD), has… byPallavi MadhirajuJuly 9, 2024